|
|
Article: TKT Confirms That Board of Directors Unanimously Recommends That Stockholders Approve Shire Transaction.
- Article from:
- PR Newswire
- Article date:
- July 14, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CAMBRIDGE, Mass., July 14 /PRNewswire-FirstCall/ -- Transkaryotic Therapies, Inc. today confirmed that its board of directors unanimously recommends that stockholders vote in favor of the proposed acquisition by Shire Pharmaceutical Group plc. at TKT's special meeting of stockholders on Wednesday, July 27, 2005.
To dispel any uncertainty regarding its position, the board clarified that its recommendation to stockholders to vote in favor of the Shire transaction is unanimous.
In a statement, the board said: "The board conducted a rigorous and deliberative process in reaching an agreement with Shire that provides full, fair and immediate cash value to ...